Clinical impact of crizotinib on central nervous system progression in ALK-positive non-small lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical impact of crizotinib on central nervous system progression in ALK-positive non-small lung cancer

Published:2016-07 Issue: Volume:97 Page:43-47
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Yoshida Tatsuya,Oya Yuko,Tanaka Kosuke,Shimizu Junichi,Horio Yoshitsugu,Kuroda Hiroaki,Sakao Yukinori,Hida Toyoaki,Yatabe Yasushi

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference23 articles.

1. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer;Soda;Nature,2007

2. Crizotinib versus chemotherapy in advanced ALK-positive lung cancer;Shaw;N. Engl. J. Med.,2013

3. First-line crizotinib in ALK-positive lung cancer;Solomon;N. Engl. J. Med.,2015

4. Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK;Katayama;Proc. Natl. Acad. Sci. U. S. A.,2011

5. Mechanisms of acquired crizotinib resistance in ALK-rearranged lung cancers;Katayama;Sci. Transl. Med.,2012

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kinase inhibitor macrocycles: a perspective on limiting conformational flexibility when targeting the kinome with small molecules;RSC Medicinal Chemistry;2024

2. Distinct metastatic spread and progression patterns in patients treated with crizotinib for ROS1- and ALK-rearranged non-small cell lung cancer: a single-center retrospective study;Translational Lung Cancer Research;2023-07

3. Efficacy and safety of anaplastic lymphoma kinase inhibitors for non–small cell lung cancer: A systematic review and network meta‐analysis;Thoracic Cancer;2023-03-13

4. The role of brain radiotherapy for EGFR- and ALK-positive non-small-cell lung cancer with brain metastases: a review;La radiologia medica;2023-02-14

5. ALK TKI therapy in patients with ALK-positive non-small cell lung cancer and brain metastases: A review of the literature and local experiences;Critical Reviews in Oncology/Hematology;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3